記住我
Research Article
Haghighat N. · Foroutan H. · Hessameddini I. · Amini M. · Hosseini B. · Moeinvaziri N. · Hosseini S.V. · Kamran H.
Introduction: SARS-CoV-2 infection (COVID-19) pandemic may influence the weight outcomes of bariatric surgeries (BS). Here, we intended to compare the weight outcome of patients who underwent bariatric surgery before and during the pandemic time. Methods: In a retrospective, single-center study, the information of two groups of patients; first COVID-19_Group (n=51) consisted of those that underwent BS during the pandemic and completed a year of follow-up, second NonCOVID-19_Group included 50 patients who underwent BS and were followed up before the pandemic. All the patients’ anthropometric and obesity-related disease data were compared between groups. Results: Weight loss and the decrease of body mass index (BMI) one year after the surgery, as well as excess weight loss and total weight loss, were significantly higher in the NonCOVID-19_Group compared to the COVID-19_Group (p 0.05). Conclusion: We showed a significantly poorer weight outcome at the one-year follow-up of the BS during the pandemic compared to the pre-pandemic. These results need further investigations to determine the preventive measures and management by evaluating the associated factors.
The Author(s). Published by S. Karger AG, Basel
Article / Publication Details Open Access License / Drug Dosage / Disclaimer This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
留言 (0)